This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Biotie Therapies Corporation. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: Panu Jaakkola: Innovator in Cellular Differentiation
Introduction
Panu Jaakkola is a notable inventor based in Turku, Finland. He has made significant contributions to the field of cellular biology, particularly in the regulation of syndecan expression. With a total of 2 patents, his work focuses on methods that enhance cellular differentiation and combat malignant cell growth.
Latest Patents
Jaakkola's latest patents include the "Syndecan enhancer element" and "Syndecan stimulation of cellular differentiation." These patents provide methods for altering levels of syndecan within a cell. The methods involve enhancing syndecan expression through the administration of growth factors and preventing its suppression via anti-steroid agents. Additionally, they detail how to alter syndecan biochemistry within the cell to induce or maintain cellular differentiation and decrease malignant cell growth. The patents also cover the application of these methods in treating patients, including humans. Furthermore, they introduce a syndecan enhancer element, novel proteins that activate this enhancer, and non-human transgenic animals that incorporate this enhancer linked to a structural gene. The enhancer element can also target gene expression to wound sites.
Career Highlights
Throughout his career, Panu Jaakkola has worked with several prominent companies, including Biotie Therapies Corporation and Biogenium Microsystems Oy. His innovative approaches have positioned him as a key figure in the development of therapeutic methods for cellular differentiation.
Collaborations
Jaakkola has collaborated with notable colleagues such as Tapani Vihinen and Markku Jalkanen. These partnerships have further enriched his research and contributed to advancements in the field.
Conclusion
Panu Jaakkola's work in enhancing syndecan expression and cellular differentiation showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving therapeutic strategies for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile